Paper - WANFANG MED ONLINE

You Position: Home > Paper

The present and future development of tumor markers for cancer screening in apparent healthy ;populations

( views:136, downloads:217 )

Author:: No author available

Journal Title:: Chinese Journal of Health Management

Issue:: 4

DOI:: 10.3760/cma.j.issn.1674-0815.2016.04.002

Key Word:: No keyword available

Abstract：随着发病率和死亡率的增加，癌症已经成为中国人群死亡的首要原因和主要的公共健康问题。据《2015中国癌症统计》的调查，中国2015年估计有429.2万例癌症新发病例，281.4万例癌症死亡，肺癌成为最常见癌症，也是癌症死亡的首要原因。胃癌、食管癌和肝癌也是常见癌症，在癌症死亡原因中排在前列[1]。故对于肿瘤患者的早期筛查与管理是肿瘤诊疗过程中极其重要的一环，亟需寻找可靠的肿瘤标志物。

Reference

[1]中华人民共和国卫生部.原发性肝癌诊疗规范（2011年版）[J].2011,(10).
[2]中华医学会消化内镜学分会,中国抗癌协会肿瘤内镜专业委员会.中国早期胃癌筛查及内镜诊治共识意见（2014年，长沙）[J].2014,(7).
[3]中华医学会检验分会,卫生部临床检验中心,中华检验医学杂志编辑委员会.肿瘤标志物的临床应用建议[J].2012,(2).
[4]Jaffer A, Ajani,David J, Bentrem,Stephen, Besh,etc.Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.[J].2013,11(5).
[5]Samir, Gupta,Stephen, Bent,Jeffrey, Kohlwes.Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.[J].2003,139(1).
[6]Schr?der,F.H.,Hugosson,J.,Roobol,M.J.,etc.Prostate-cancer mortality at 11 years of follow-up[J].2012,366(11).
[7]Shaukat,A.,Mongin,S.J.,Geisser,M.S.,etc.Long-term mortality after screening for colorectal cancer[J].2013,369(12).
[8]Chen, Wanqing,Zheng, Rongshou,Baade, Peter D.,etc.Cancer Statistics in China, 2015[J].2016,66(2).
[9]Diez Alonso M,Arribas I,Gaspar MJ,etc.Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.[J].2001,22(5).
[10]Robert A. Smith PhD,Kimberly Andrews,Durado Brooks MD, MPH,etc.Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening[J].2016,(2).
[11].American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer[J].2012,62(3).
[12]Kodera Y,Kaminishi M,Katai H,etc.Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry.[J].2011,14(4).
[13]Reding DJ,Buys SS,Chia D,etc.Mortality results from a randomized prostate-cancer screening trial.[J].2009,360(13).
[14][Noauthornameavailable].EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma[J].2012,56(4).
[15]Imperiale,T.F.,Ransohoff,D.F.,Itzkowitz,S.H.,etc.Multitarget stool DNA testing for colorectal-cancer screening[J].2014,370(14).
[16]Bruix J,Sherman M.Management of hepatocellular carcinoma: an update.[J].2011,53(3).
[17]Moyer,V.A..Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. preventive services task force recommendation statement[J].2014,160(4).
[18]Martinez-Morillo, Eduardo,Miquel Bauca, Josep,Diamandis, Eleftherios P..Peptidomics of Urine and Other Biofluids for Cancer Diagnostics[J].2014,60(8).
[19]Miki K,Matsukawa M,Yamaki G,etc.Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening.[J].2004,11(3).
[20]Steenbergen,R.D.M.,Snijders,P.J.F.,Heideman,D.A.M.,etc.Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions[J].2014,14(6).